Back to top
more

Terumo (TRUMY)

(Delayed Data from OTC)

$19.16 USD

19.16
50,414

+0.46 (2.46%)

Updated Sep 19, 2024 03:59 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth A Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 27% (68 out of 251)

Industry: Medical - Products

Better trading starts here.

Balance Sheet

Research for TRUMY

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for Terumo Corp falls in the month of March.

All items in Millions except Per Share data.

3/31/2024 3/31/2023 3/31/2022 3/31/2021 3/31/2020
Assets          
Cash & Equivalents 1,594 1,387 1,827 1,898 1,539
Receivables 1,242 1,136 1,217 1,215 1,228
Notes Receivable 0 0 0 0 0
Inventories 1,978 1,847 1,767 1,650 1,354
Other Current Assets 169 154 161 162 117
Total Current Assets 4,983 4,524 4,973 4,925 4,238
Net Property & Equipment 2,869 2,744 2,971 2,817 2,433
Investments & Advances 17 27 37 34 49
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 138 151 180 223 251
Intangibles 4,059 3,983 4,582 4,435 4,246
Deposits & Other Assets 572 426 374 266 205
Total Assets 12,637 11,856 13,116 12,701 11,420
Liabilities & Shareholders Equity 3/31/2024 3/31/2023 3/31/2022 3/31/2021 3/31/2020
Notes Payable 0 0 0 0 0
Accounts Payable 647 723 726 785 810
Current Portion Long-Term Debt 1,082 83 10 395 463
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 0 0 0 0 0
Income Taxes Payable 183 174 126 135 107
Other Current Liabilities 704 633 720 672 569
Total Current Liabilities 2,616 1,613 1,582 1,987 1,949
Mortgages 0 0 0 0 0
Deferred Taxes/Income 21 66 113 150 187
Convertible Debt 0 0 0 0 0
Long-Term Debt 517 1,633 2,001 2,054 1,802
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 325 322 410 458 537
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 3,480 3,635 4,106 4,649 4,476
Shareholders Equity 3/31/2024 3/31/2023 3/31/2022 3/31/2021 3/31/2020
Preferred Stock 0 0 0 0 0
Common Stock (Par) 267 287 345 364 356
Capital Surplus 357 383 462 487 477
Retained Earnings 6,587 6,470 7,538 7,286 6,493
Other Equity 2,031 1,168 720 -20 -252
Treasury Stock 86 85 55 64 130
Total Shareholder's Equity 9,157 8,222 9,010 8,053 6,945
Total Liabilities & Shareholder's Equity 12,637 11,856 13,116 12,701 11,420
Total Common Equity 9,157 8,222 9,010 8,053 6,945
Shares Outstanding 1,490.70 1,495.30 1,519.00 1,519.00 1,519.00
Book Value Per Share 6.14 5.50 5.93 5.30 4.57

Fiscal Year End for Terumo Corp falls in the month of March.

All items in Millions except Per Share data.

6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Assets          
Cash & Equivalents 1,259 1,594 1,233 1,458 1,308
Receivables 1,194 1,242 1,236 1,178 1,172
Notes Receivable 0 0 NA NA 0
Inventories 1,921 1,978 1,853 1,932 1,989
Other Current Assets 162 169 226 153 157
Total Current Assets 4,536 4,983 4,549 4,721 4,626
Net Property & Equipment 2,755 2,869 2,649 2,766 2,841
Investments & Advances 16 17 14 15 26
Other Non-Current Assets 0 0 NA NA 0
Deferred Charges 147 138 148 149 155
Intangibles 3,949 4,059 3,957 4,072 4,210
Deposits & Other Assets 558 572 186 341 338
Total Assets 11,961 12,637 11,503 12,064 12,197
Liabilities & Shareholders Equity 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Notes Payable 0 0 NA NA 0
Accounts Payable 555 647 594 596 624
Current Portion Long-Term Debt 224 1,082 1,028 1,079 1,123
Current Portion Capital Leases 0 0 NA NA 0
Accrued Expenses 0 0 NA NA 0
Income Taxes Payable 143 183 135 162 117
Other Current Liabilities 600 704 631 645 613
Total Current Liabilities 1,522 2,616 2,388 2,481 2,477
Mortgages 0 0 NA NA 0
Deferred Taxes/Income 32 21 23 42 63
Convertible Debt 0 0 NA NA 0
Long-Term Debt 1,023 517 510 517 547
Non-Current Capital Leases 0 0 NA NA 0
Other Non-Current Liabilities 306 313 322 330
Minority Interest (Liabilities) 0 0 NA NA 0
Total Liabilities 2,883 3,480 3,234 3,363 3,417
Shareholders Equity 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Preferred Stock 0 0 NA NA 0
Common Stock (Par) 248 267 263 267 283
Capital Surplus 332 357 351 356 378
Retained Earnings 6,222 6,587 6,270 6,271 6,432
Other Equity 2,355 2,031 1,514 1,884 1,770
Treasury Stock 78 86 130 77 83
Total Shareholder's Equity 9,078 9,157 8,269 8,701 8,779
Total Liabilities & Shareholder's Equity 11,961 12,637 11,503 12,064 12,197
Total Common Equity 9,078 9,157 108,268 108,700 8,779
Shares Outstanding 1,490.70 1,490.70 1,495.30 1,495.30 1,495.30
Book Value Per Share 6.09 6.14 72.41 72.69 5.87